Search research articles
Contact Us
Filters
Showing results (41-50 of 75) with videos related to
Page
of 8
Sort By:
British Journal of Pharmacology
|
July 29, 2025
Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?
Omar Qureshi, Jamie Cowley, Ashley Pegg, et al.
Blood
|
January 8, 2003
Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells
Adamantios Serafeim, Michelle J Holder, Gillian Grafton, et al.
Frontiers in Pharmacology
|
September 16, 2022
The mechanism of action of a novel neuroprotective low molecular weight dextran sulphate: New platform therapy for neurodegenerative diseases like Amyotrophic Lateral Sclerosis
Ann Logan, Antonio Belli, Valentina Di Pietro, et al.
British Journal of Pharmacology
|
April 19, 2013
5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor
Amy S Newman, Nikolaos Batis, Gillian Grafton, et al.
Npj Aging
|
May 29, 2026
Psychosis as a multisystem disorder of aberrant aging
Rachel Upthegrove, Amalie C M Couch, Antonio de Marvao, et al.
RSC Chemical Biology
|
January 3, 2022
Design, synthesis and evaluation of tryptophan analogues as tool compounds to study IDO1 activity
Nicholas J Cundy, Roseanna K Hare, Tina Tang, et al.
International Journal of Molecular Sciences
|
August 12, 2022
ILB<sup>®</sup>, a Low Molecular Weight Dextran Sulphate, Restores Glutamate Homeostasis, Amino Acid Metabolism and Neurocognitive Functions in a Rat Model of Severe Traumatic Brain Injury
Giacomo Lazzarino, Valentina Di Pietro, Marco Rinaudo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 5, 2005
The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics
Elizabeth J Meredith, Michelle J Holder, Anita Chamba, et al.
Mabs
|
January 19, 2024
Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells <i>in vitro</i>
Omar S Qureshi, Emma J Sutton, Rosemary F Bithell, et al.
Investigational New Drugs
|
August 19, 2011
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death
Agata M Wasik, Michael N Gandy, Matthew McIldowie, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 75) with videos related to
Sort By:
Page
of 8
British Journal of Pharmacology
|
July 29, 2025
Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?
Omar Qureshi, Jamie Cowley, Ashley Pegg, et al.
Blood
|
January 8, 2003
Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells
Adamantios Serafeim, Michelle J Holder, Gillian Grafton, et al.
Frontiers in Pharmacology
|
September 16, 2022
The mechanism of action of a novel neuroprotective low molecular weight dextran sulphate: New platform therapy for neurodegenerative diseases like Amyotrophic Lateral Sclerosis
Ann Logan, Antonio Belli, Valentina Di Pietro, et al.
British Journal of Pharmacology
|
April 19, 2013
5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor
Amy S Newman, Nikolaos Batis, Gillian Grafton, et al.
Npj Aging
|
May 29, 2026
Psychosis as a multisystem disorder of aberrant aging
Rachel Upthegrove, Amalie C M Couch, Antonio de Marvao, et al.
RSC Chemical Biology
|
January 3, 2022
Design, synthesis and evaluation of tryptophan analogues as tool compounds to study IDO1 activity
Nicholas J Cundy, Roseanna K Hare, Tina Tang, et al.
International Journal of Molecular Sciences
|
August 12, 2022
ILB<sup>®</sup>, a Low Molecular Weight Dextran Sulphate, Restores Glutamate Homeostasis, Amino Acid Metabolism and Neurocognitive Functions in a Rat Model of Severe Traumatic Brain Injury
Giacomo Lazzarino, Valentina Di Pietro, Marco Rinaudo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 5, 2005
The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics
Elizabeth J Meredith, Michelle J Holder, Anita Chamba, et al.
Mabs
|
January 19, 2024
Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells <i>in vitro</i>
Omar S Qureshi, Emma J Sutton, Rosemary F Bithell, et al.
Investigational New Drugs
|
August 19, 2011
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death
Agata M Wasik, Michael N Gandy, Matthew McIldowie, et al.
Page
of 8